IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

Nature

Volumn 507, Issue 7492, 2014, Pages 366-370

  Shen, Ping ^a   Roch, Toralf ^a,j   Lampropoulou, Vicky ^a   O'Connor, Richard A ^b   Stervbo, Ulrik ^a   Hilgenberg, Ellen ^a   Ries, Stefanie ^a   Dang, Van Duc ^a   Jaimes, Yarúa ^a   Daridon, Capucine ^a,c   Li, Rui ^d   Jouneau, Luc ^e   Boudinot, Pierre ^e   Wilantri, Siska ^a   Sakwa, Imme ^a   Miyazaki, Yusei ^d   Leech, Melanie D ^b   McPherson, Rhoanne C ^b   Wirtz, Stefan ^f   Neurath, Markus ^f   Hoehlig, Kai ^a   Meinl, Edgar ^g   Grützkau, Andreas ^a   Grün, Joachim R ^a   Horn, Katharina ^a   Kühl, Anja A ^h   Dörner, Thomas ^a,c   Bar Or, Amit ^d   Kaufmann, Stefan H E ⁱ   Anderton, Stephen M ^b   Fillatreau, Simon ^a   more..

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MCGILL UNIVERSITY   (Canada)

^e INRA Institut National de la Recherche Agronomique   (France)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h Immunpathologie Research Center ImmunoSciences   (Germany)

ⁱ MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^j INSTITUTE OF MATERIALS RESEARCH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD1D ANTIGEN; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 10; INTERLEUKIN 35; KIDNEY INJURY MOLECULE 1; SYNDECAN 1; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

BACTERIUM; CELL ORGANELLE; GENE EXPRESSION; HOST-PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNITY; INFECTIOUS DISEASE; INHIBITOR; RODENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL SURVIVAL; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOREGULATION; INFECTION RESISTANCE; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PLASMA CELL; PRIMARY INFECTION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SURFACE PROPERTY; T LYMPHOCYTE ACTIVATION;

BACTERIA (MICROORGANISMS); MUS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; B-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; IMMUNITY; INTERLEUKIN-10; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MALE; MICE; PLASMA CELLS; SALMONELLA INFECTIONS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4;

EID: 84897027520     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12979     Document Type: Article

References (31)

1. Fillatreau, S., Gray, D. & Anderton, S. M. Not always the bad guys: B cells as regulators of autoimmune pathology. Nature Rev. Immunol. 8, 391-397 (2008).
2. Fillatreau, S. Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection. Immunol. Rev. 240, 52-71 (2011).
3. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nature Immunol. 3, 944-950 (2002).
4. Mauri, C., Gray, D., Mushtaq, N. & Londei, M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197, 489-501 (2003).
5. Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. & Bhan, A. K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219-230 (2002).
6. Neves, P. et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33, 777-790 (2010).
7. Duddy, M. et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178, 6092-6099 (2007).
8. Jagannathan, M. et al. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 53, 1461-1471 (2010).
9. Benedetti, L. et al. Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. Arch. Neurol. 64, 1531-1533 (2007).
10. Goetz, M., Atreya, R., Ghalibafian, M., Galle, P. R. & Neurath, M. F. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm. Bowel Dis. 13, 1365-1368 (2007).
11. El Fassi, D., Nielsen, C. H., Kjeldsen, J., Clemmensen, O. & Hegedus, L. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves? disease. Gut 57, 714-715 (2008).
12. Dass, S., Vital, E. M.&Emery, P. Development of psoriasis afterB cell depletion with rituximab. Arthritis Rheum. 56, 2715-2718 (2007).
13. Wilson, M. S. et al. Helminth-induced CD191CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur. J. Immunol. 40, 1682-1696 (2010).
14. Su, Y., Zhang, A. H., Noben-Trauth, N. & Scott, D. W. B-cell gene therapy for tolerance induction: Host but not donor B-cell derived IL-10 is necessary for tolerance. Front. Microbiology 2, http://dx.doi.org/10.3389/fmicb. 2011.00154 (2011).
15. Lampropoulou, V. et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180, 4763-4773 (2008).
16. Devergne, O., Birkenbach, M. & Kieff, E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl Acad. Sci. USA 94, 12041-12046 (1997).
17. Collison, L. W. et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450, 566-569 (2007).
18. Niedbala, W. et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37, 3021-3029 (2007).
19. Villarino, A. et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19, 645-655 (2003).
20. Brentano, F. et al. Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: Differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis. Ann. Rheum. Dis. 68, 143-150 (2009).
21. Kuchroo, V. K. et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151, 4371-4382 (1993).
22. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin. Nature Immunol. 6, 1133-1141 (2005).
23. Bettini, M., Castellaw, A. H., Lennon, G. P., Burton, A. R. & Vignali, D. A. Prevention of autoimmune diabetes by ectopic pancreatic b-cell expression of interleukin-35. Diabetes 61, 1519-1526 (2012).
24. McGeachy, M. J., Stephens, L. A. & Anderton, S. M. Natural recovery and protection from autoimmune encephalomyelitis: Contribution of CD41CD251 regulatory cells within the central nervous system. J. Immunol. 175, 3025-3032 (2005).
25. Weber, M. S. et al. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann. Neurol. 68, 369-383 (2010).
26. Mittru?cker, H. W.& Kaufmann, S. H. Immune response to infection with Salmonella typhimurium in mice. J. Leukoc. Biol. 67, 457-463 (2000).
27. Barr, T. A. et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209, 1001-1010 (2012).
28. Chan, Y. H. et al. Absence of the transcriptional repressor Blimp-1 in hematopoietic lineages reveals its role in dendritic cell homeostatic development and function. J. Immunol. 183, 7039-7046 (2009).
29. Biesen, R. et al. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum. 58, 1136-1145 (2008).
30. Saeed, A. I. et al. TM4: A free, open-source system for microarray data management and analysis. Biotechniques 34, 374-378 (2003).
31. Hoehlig, K. et al. Activation of CD41 Foxp31 regulatory T cells proceeds normally in the absence of B cells during EAE. Eur. J. Immunol. 42, 1164-1173 (2012).